Select a Community
Are you sure you want to trigger topic in your Anconeus AI algorithm?
You are done for today with this topic.
Would you like to start learning session with this topic items scheduled for future?
#
|
Topic
|
Subspecialty
|
Importance
|
Questions
|
---|---|---|---|---|
301 | Yersinia pestis | Microbiology | 2 | |
302 | Stains | Microbiology | 4 | |
303 | Special Culture Requirements | Microbiology | 3 | |
304 | Variola | Microbiology | 0 | |
305 | Staphylococcus epidermidis | Microbiology | 0 | |
306 | Streptococcus pneumoniae | Microbiology | 8 | |
307 | Viridans Group Streptococci | Microbiology | 2 | |
308 | Streptococcus pyogenes (Group A Streptococci) | Microbiology | 9 | |
309 | Streptococcus agalactiae (Group B Streptococci) | Microbiology | 1 | |
310 | Streptococcus bovis/gallolyticus (Group D Streptococci) | Microbiology | 0 | |
311 | Ureaplasma urealyticum | Microbiology | 0 | |
312 | Shigella dysenteriae | Microbiology | 4 | |
313 | Yersinia enterocolitica | Microbiology | 2 | |
314 | Varicella Zoster Virus | Microbiology | 4 | |
315 | Treponema pallidum / Syphilis | Microbiology | 7 | |
316 | Vibrio cholerae | Microbiology | 3 | |
317 | Vibrio parahaemolyticus / vulnificus | Microbiology | 2 | |
318 | Rickettsiae | Microbiology | 1 | |
319 | Serratia | Microbiology | 1 | |
320 | Systemic Mycoses | Microbiology | 7 | |
321 | Viral Genetics | Microbiology | 5 | |
322 | Vaccines | Microbiology | 1 | |
323 | Viral Envelopes | Microbiology | 3 | |
324 | Rhinovirus | Microbiology | 0 | |
325 | Yellow Fever Virus | Microbiology | 1 | |
326 | Rotavirus | Microbiology | 2 | |
327 | Rubella Virus | Microbiology | 3 | |
328 | Rubeola (Measles) | Microbiology | 3 | |
329 | ToRCHeS Infections | Microbiology | 2 | |
330 | Sexually Transmitted Infections | Microbiology | 0 | |
331 | Vancomycin | Microbiology | 3 | |
332 | Tetracyclines | Microbiology | 3 | |
333 | Sulfonamides | Microbiology | 1 | |
334 | Trimethoprim | Microbiology | 2 | |
335 | Reverse Transcriptase Inhibitors | Microbiology | 0 | |
336 | Rifamycins | Microbiology | 2 | |
337 | Terbinafine | Microbiology | 2 | |
338 | Ribavirin | Microbiology | 1 | |
339 | Staphylococcus aureus | Microbiology | 6 | |
340 | Salmonella typhi | Microbiology | 2 | |
341 | Staphylococcus saprophyticus | Microbiology | 2 | |
342 | RNA Viruses | Microbiology | 2 | |
343 | Asplenia | Immunology | 3 | |
344 | Ataxia-Telangiectasia | Immunology | 1 | |
345 | Severe Combined Immunodeficiency Disorder (SCID) | Immunology | 7 | |
346 | Wiskott-Aldrich Syndrome | Immunology | 5 | |
347 | Superantigens | Immunology | 1 | |
348 | Leukocyte Adhesion Deficiency Type I | Immunology | 5 | |
349 | Chediak-Higashi Syndrome | Immunology | 3 | |
350 | Hyper IgE Syndrome / Job Syndrome | Immunology | 2 | |
351 | Chronic Granulomatous Disease | Immunology | 6 | |
352 | Hereditary Angioedema | Immunology | 4 | |
353 | Hyper IgM Syndrome | Immunology | 4 | |
354 | Selective IgA Deficiency | Immunology | 1 | |
355 | Transient Hypogammaglobulinemia of Infancy | Immunology | 0 | |
356 | Bruton Agammaglobulinemia | Immunology | 8 | |
357 | Common Variable Immunodeficiency Disorder (CVID) | Immunology | 2 | |
358 | Chronic Mucocutaneous Candidiasis | Immunology | 1 | |
359 | IL-12 Receptor Deficiency | Immunology | 2 | |
360 | Recombinant Cytokines | Immunology | 1 | |
361 | Innate vs. Adaptive Immunity | Immunology | 0 | |
362 | Cells of the Immune System | Immunology | 5 | |
363 | Primary Lymphoid Tissue | Immunology | 2 | |
364 | Secondary Lymphoid Tissue | Immunology | 4 | |
365 | Hypersensitivity | Immunology | 16 | |
366 | Memory | Immunology | 0 | |
367 | Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) | Immunology | 1 | |
368 | T-Cell Activation | Immunology | 2 | |
369 | Cell-Mediated Immunity | Immunology | 8 | |
370 | Structure and Function of MHC | Immunology | 1 | |
371 | Complement | Immunology | 4 | |
372 | Transplant | Immunology | 11 | |
373 | Antigen-Antibody Interactions | Immunology | 0 | |
374 | Agglutination | Immunology | 0 | |
375 | Fluorescent Antibody Tests | Immunology | 0 | |
376 | Enzyme-Linked Immunosorbent Assay (ELISA) | Immunology | 0 | |
377 | Western Blot | Immunology | 0 | |
378 | Fluorescence-Activated Cell Sorter (FACS) | Immunology | 0 | |
379 | Antibodies | Immunology | 8 | |
380 | Humoral-Mediated Immunity | Immunology | 5 | |
381 | Innate Immune Response | Immunology | 7 | |
382 | Lymphocyte Development and Structure | Immunology | 4 | |
383 | MHC Deficiency | Immunology | 1 | |
384 | Antigen Processing and Presentation | Immunology | 2 | |
385 | Immunization | Immunology | 3 | |
386 | Human Immunodeficiency Virus / Acquired Immunodeficiency Syndrome | Immunology | 0 | |
387 | Immunosuppressive Drugs | Immunology | 8 | |
388 | Autoimmunity | Immunology | 0 | |
389 | Apoptosis | Pathology | 6 | |
390 | Infarcts | Pathology | 1 | |
391 | Inflammation | Pathology | 4 | |
392 | Transudate vs. Exudate | Pathology | 2 | |
393 | Leukocyte Extravasation | Pathology | 1 | |
394 | Free Radical Injury | Pathology | 1 | |
395 | Amyloidosis | Pathology | 3 | |
396 | Shock | Pathology | 5 | |
397 | Psammoma Bodies | Pathology | 4 | |
398 | Erythrocyte Sedimentation Rate | Pathology | 1 | |
399 | Necrosis | Pathology | 4 | |
400 | Cell Injury | Pathology | 3 | |
401 | Organophosphate Poisoning | Pharmacology | 3 | |
402 | Enzyme Kinetics | Pharmacology | 3 | |
403 | Pharmacokinetics | Pharmacology | 5 | |
404 | Dosage Calculations | Pharmacology | 3 | |
405 | Elimination of Drugs | Pharmacology | 1 | |
406 | Drug Excretion | Pharmacology | 3 | |
407 | Phase I vs. Phase II Metabolism | Pharmacology | 1 | |
408 | Efficacy vs. Potency | Pharmacology | 2 | |
409 | Pharmacodynamics | Pharmacology | 1 | |
410 | Therapeutic Index | Pharmacology | 3 | |
411 | Central and Peripheral Nervous System | Pharmacology | 0 | |
412 | G Protein-Coupled Receptors (GPCR) | Pharmacology | 6 | |
413 | Autonomic Pathways | Pharmacology | 3 | |
414 | Cholinomimetic Agents | Pharmacology | 5 | |
415 | Muscarinic Antagonists | Pharmacology | 5 | |
416 | Ganglionic Blockers | Pharmacology | 1 | |
417 | Sympathomimetics | Pharmacology | 13 | |
418 | Alpha-Blockers | Pharmacology | 3 | |
419 | Beta-Blockers | Pharmacology | 7 | |
420 | Poisons and Treatments | Pharmacology | 19 | |
421 | Drug Reactions and Side Effects | Pharmacology | 12 | |
422 | Drug Interactions | Pharmacology | 2 | |
423 | Medication Nomenclature | Pharmacology | 0 | |
424 | Atrioventricular (AV) Heart Block | Cardiovascular | 9 | |
425 | Baroreceptors and Chemoreceptors | Cardiovascular | 8 | |
426 | Autoregulation | Cardiovascular | 3 | |
427 | Capillary Fluid Exchange | Cardiovascular | 1 | |
428 | Arteriosclerosis | Cardiovascular | 2 | |
429 | Aortic Dissection | Cardiovascular | 3 | |
430 | Atherosclerosis | Cardiovascular | 9 | |
431 | Angina | Cardiovascular | 3 | |
432 | Abdominal Aortic Aneurysm | Cardiovascular | 4 | |
433 | Antihypertensive Therapy | Cardiovascular | 10 | |
434 | Antianginal Therapy | Cardiovascular | 12 | |
435 | Atrial Arrhythmias | Cardiovascular | 4 | |
436 | Atrial Septal Defects | Cardiovascular | 4 | |
437 | Antiarrhythmics | Cardiovascular | 17 | |
438 | Behcet Syndrome | Cardiovascular | 0 | |
439 | West Nile Virus | Microbiology | 0 | |
440 | RSV | Microbiology | 1 | |
441 | Selenium Sulfide | Microbiology | 0 | |
442 | Visceral Infections: Protozoa | Microbiology | 3 | |
443 | STDs: Protozoa | Microbiology | 1 | |
444 | Tapeworms (Cestodes) | Microbiology | 3 | |
445 | Roundworms (Nematodes) | Microbiology | 7 | |
446 | Salicylate/Aspirin Overdose | Pharmacology | 2 | |
447 | Zika Virus | Microbiology | 0 | |
448 | Tigecycline | Microbiology | 0 | |
449 | Streptogramins | Microbiology | 0 | |
450 | Togaviruses | Microbiology | 0 |